Enronsubemab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enronsubemab, covering 2025-12-30 to 2025-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer [Phase 2]